Where High-Mobility Group Box 1 (HMGB1) is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Epilepsy | ↑ elevated | drug-responsive, well-controlled seizures and healthy controls | — | Walker et al. 2022 |
Frequently asked questions
In which conditions is High-Mobility Group Box 1 (HMGB1) altered?
In the OSMF atlas High-Mobility Group Box 1 (HMGB1) is reported in Epilepsy. It is elevated in 1 across 1 entries.
Is there a standard clinical test for High-Mobility Group Box 1 (HMGB1)?
The atlas entries for High-Mobility Group Box 1 (HMGB1) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal High-Mobility Group Box 1 (HMGB1) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.